CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common Stock	Treasury Shares	Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2019		477,000,000
Beginning balance (in shares) at Dec. 31, 2019			79,000,000
Balance at beginning of period at Dec. 31, 2019	$ 2,151	$ 48	$ (1,823)	$ 1,782	$ 1	$ 2,143
Increase (Decrease) in Stockholders' Equity
Net income	201					201
Stock amortization and vesting (in shares)		1,000,000
Stock amortization and vesting	$ 22			22
Common stock repurchases (in shares)	0
Common stock retirements	$ 0
Common stock cash dividends	(159)					(159)
Other comprehensive income	1				1
Ending balance (in shares) at Dec. 31, 2020		478,000,000
Ending balance (in shares) at Dec. 31, 2020			79,000,000
Balance at end of period at Dec. 31, 2020	2,216	$ 48	$ (1,823)	1,804	2	2,185
Increase (Decrease) in Stockholders' Equity
Net income	1,158					1,158
Issuance of common stock for merger (in shares)		408,000,000
Issuance of common stock for merger	9,083	$ 41		9,042
Issuance of replacement awards and options for merger consideration (in shares)		4,000,000
Issuance of replacement awards and options for merger consideration	37			37
Exercise of stock options	2			2
Stock amortization and vesting (in shares)		3,000,000
Stock amortization and vesting	$ 23		$ (3)	26
Common stock repurchases (in shares)	0
Common stock retirements	$ 0
Common stock cash dividends	(779)					(779)
Preferred stock cash dividends	(1)					(1)
Other comprehensive income	$ (1)				(1)
Ending balance (in shares) at Dec. 31, 2021		893,000,000
Ending balance (in shares) at Dec. 31, 2021	79,082,385		79,000,000
Balance at end of period at Dec. 31, 2021	$ 11,738	$ 89	$ (1,826)	10,911	1	2,563
Increase (Decrease) in Stockholders' Equity
Net income	$ 4,065					4,065
Exercise of stock options (in shares)	780,606	1,000,000
Exercise of stock options	$ 12			12
Stock amortization and vesting (in shares)		1,000,000	1,000,000
Stock amortization and vesting	$ 46	$ 1	$ (9)	54
Common stock repurchases (in shares)	48,000,000		48,000,000
Common stock repurchases	$ (1,250)		$ (1,250)
Common stock retirements (in shares)		(128,000,000)	(128,000,000)
Common stock retirements	0	$ (13)	$ 3,085	(3,072)
Conversion of Cimarex redeemable preferred stock (in shares)		1,000,000
Conversion of Cimarex redeemable preferred stock	28			28
Common stock cash dividends	(1,991)					(1,991)
Preferred stock cash dividends	(1)					(1)
Other comprehensive income	$ 12				12
Ending balance (in shares) at Dec. 31, 2022		768,000,000
Ending balance (in shares) at Dec. 31, 2022	0		0
Balance at end of period at Dec. 31, 2022	$ 12,659	$ 77	$ 0	$ 7,933	$ 13	$ 4,636